Filing Overview
Registrant: Blue Water Vaccines Inc. The request metadata identifies Onconetix, Inc., which does not match the registrant named in the filing.
Form and date: Form 8-K dated March 9, 2023, signed March 13, 2023. The filing reports financial results for the fiscal year ended December 31, 2022 and recent business highlights.
Reporting item: Item 7.01, Regulation FD disclosure. The company furnished a March 9, 2023 press release as Exhibit 99.1.
Financial and Operating Information
The provided filing text does not include the contents of Exhibit 99.1. Accordingly, it does not provide clear values for revenue, net income or loss, cash flow, margins, debt, liquidity, cash balances, or other financial metrics.
Changes Versus Prior Period
The filing states that the press release reports fiscal-year 2022 financial results and recent business highlights, but the provided text does not describe the results or quantify changes versus the prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, risk factors, contingencies, or unusual items are described in the filing text provided. These matters may be addressed in the omitted Exhibit 99.1 press release.
Investor Verification Items
- Obtain and review Exhibit 99.1 for the complete fiscal-year 2022 results and business highlights.
- Verify revenue, earnings, cash flow, cash and liquidity, debt, and any non-GAAP measures disclosed in the press release.
- Check for management guidance, operating milestones, financing needs, contingencies, and other risks.
- Reconcile the registrant name: the filing identifies Blue Water Vaccines Inc., while the request metadata identifies Onconetix, Inc.
- Confirm that the press release is furnished under Item 7.01 and is not deemed filed for purposes of Section 18 liability or incorporated by reference into other filings.